Omnicell, Inc. (NASDAQ:OMCL) Stake Increased by Swiss National Bank

Swiss National Bank increased its holdings in shares of Omnicell, Inc. (NASDAQ:OMCL) by 0.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 90,500 shares of the company’s stock after buying an additional 800 shares during the quarter. Swiss National Bank owned 0.20% of Omnicell worth $4,029,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently bought and sold shares of the business. Smartleaf Asset Management LLC increased its holdings in Omnicell by 51.5% in the fourth quarter. Smartleaf Asset Management LLC now owns 803 shares of the company’s stock worth $35,000 after buying an additional 273 shares during the last quarter. Van ECK Associates Corp grew its position in Omnicell by 47.0% in the fourth quarter. Van ECK Associates Corp now owns 985 shares of the company’s stock worth $44,000 after acquiring an additional 315 shares in the last quarter. First Horizon Advisors Inc. increased its stake in shares of Omnicell by 36.3% during the 4th quarter. First Horizon Advisors Inc. now owns 1,333 shares of the company’s stock worth $59,000 after purchasing an additional 355 shares during the last quarter. KBC Group NV raised its holdings in shares of Omnicell by 60.8% during the 4th quarter. KBC Group NV now owns 2,057 shares of the company’s stock valued at $92,000 after purchasing an additional 778 shares in the last quarter. Finally, AlphaQuest LLC lifted its stake in shares of Omnicell by 307.8% in the 4th quarter. AlphaQuest LLC now owns 3,576 shares of the company’s stock valued at $159,000 after purchasing an additional 2,699 shares during the last quarter. 97.70% of the stock is owned by institutional investors and hedge funds.

Omnicell Trading Down 1.9 %

OMCL opened at $34.47 on Wednesday. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.37 and a quick ratio of 1.22. The firm has a market capitalization of $1.61 billion, a PE ratio of 127.67, a P/E/G ratio of 7.53 and a beta of 0.85. Omnicell, Inc. has a fifty-two week low of $25.12 and a fifty-two week high of $55.75. The company’s 50-day moving average is $39.47 and its 200 day moving average is $42.75.

Omnicell (NASDAQ:OMCL) last posted its quarterly earnings results on Thursday, February 6th. The company reported $0.45 EPS for the quarter, missing analysts’ consensus estimates of $0.57 by ($0.12). Omnicell had a return on equity of 3.82% and a net margin of 1.13%. As a group, research analysts predict that Omnicell, Inc. will post 1.09 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research firms recently issued reports on OMCL. Bank of America lowered their target price on shares of Omnicell from $54.00 to $46.00 and set a “neutral” rating on the stock in a research note on Monday, January 6th. Benchmark restated a “buy” rating and issued a $62.00 price objective on shares of Omnicell in a report on Tuesday, February 4th. StockNews.com lowered Omnicell from a “buy” rating to a “hold” rating in a research report on Monday. JPMorgan Chase & Co. reduced their price objective on shares of Omnicell from $44.00 to $36.00 and set a “neutral” rating for the company in a research note on Thursday, March 20th. Finally, Wells Fargo & Company decreased their price objective on shares of Omnicell from $49.00 to $40.00 and set an “equal weight” rating on the stock in a report on Monday, January 13th. Five research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $51.00.

Omnicell Company Profile

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.